Tech Company M&A Transactions
AngioScore Acquisition
Operating out of Fremont, AngioScore was bought by Spectranetics. The transaction price was $230 million.
Transaction Overview
Company Name
Acquired By
Announced On
5/27/2014
Transaction Type
M&A
Amount
$230,000,000
M&A Terms
The Spectranetics Corporation SPNC -8.25% today announced that it has entered into a definitive merger agreement under which Spectranetics will acquire AngioScore Inc., a leading developer, manufacturer and marketer of cardiovascular, specialty balloons for $230 million in up-front consideration, along with additional contingent commercial and regulatory milestone payments.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
5055 Brandin Ct.
Fremont, CA 94538
USA
Fremont, CA 94538
USA
Phone
Website
Email Address
Overview
AngioScore, Inc. develops, makes and sells leading edge tools for endovascular therapy. Our first product, the AngioSculpt Scoring Balloon Catheter, has received CE mark approval and is available for sale in Europe. Clinical trials are underway in the United States.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Trotter
Chief Financial Officer
James Andrews
Chief Medical Officer
Gary Gershony
VP - Operations
Samuel Omaleki
VP - Regulatory Affairs
Kent Jones
VP - Sales
Richard Cassidy
Browse more venture capital transactions:
Prev: 5/26/2014: Healthify venture capital transaction
Next: 5/27/2014: Teachers Pay Teachers venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records on this site are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs